Yulia Green

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 973 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Dual bronchodilation with QVA149<i>versus</i>single bronchodilator therapy: the SHINE study

Eric Bateman, Gary T. Ferguson, Neil Barnes et al. · European Respiratory Journal · 2013 · 381 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

Jane C. Davies, Steve Cunningham, William T. Harris et al. · The Lancet Respiratory Medicine · 2016 · 345 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Brad H. Rovin, Richard Furie, Y K Onno Teng et al. · Kidney International · 2021 · 198 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study

David Jayne, Daniël Blockmans, Raashid Luqmani et al. · Arthritis & Rheumatology · 2019 · 139 citations · Full text

Life Sciences, Clinical Sciences, Pharmacology +16